129 related articles for article (PubMed ID: 12795781)
1. Facile and rapid high-performance liquid chromatography method for simultaneous determination of allopurinol and oxypurinol in human serum.
Tada H; Fujisaki A; Itoh K; Suzuki T
J Clin Pharm Ther; 2003 Jun; 28(3):229-34. PubMed ID: 12795781
[TBL] [Abstract][Full Text] [Related]
2. Determination of allopurinol and oxypurinol in human plasma and urine by liquid chromatography-tandem mass spectrometry.
Liu X; Ni XJ; Shang DW; Zhang M; Hu JQ; Qiu C; Luo FT; Wen YG
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 941():10-6. PubMed ID: 24184830
[TBL] [Abstract][Full Text] [Related]
3. Bioequivalence of allopurinol-containing tablet preparations.
Barthel W; Hüller G; Haustein KO
Int J Clin Pharmacol Ther; 1999 Mar; 37(3):148-52. PubMed ID: 10190763
[TBL] [Abstract][Full Text] [Related]
4. The population pharmacokinetics of allopurinol and oxypurinol in patients with gout.
Wright DF; Stamp LK; Merriman TR; Barclay ML; Duffull SB; Holford NH
Eur J Clin Pharmacol; 2013 Jul; 69(7):1411-21. PubMed ID: 23475133
[TBL] [Abstract][Full Text] [Related]
5. A simple method for quantification of allopurinol and oxipurinol in human serum by high-performance liquid chromatography with UV-detection.
Reinders MK; Nijdam LC; van Roon EN; Movig KL; Jansen TL; van de Laar MA; Brouwers JR
J Pharm Biomed Anal; 2007 Oct; 45(2):312-7. PubMed ID: 17890037
[TBL] [Abstract][Full Text] [Related]
6. A population pharmacokinetic model to predict oxypurinol exposure in patients on haemodialysis.
Wright DF; Doogue MP; Barclay ML; Chapman PT; Cross NB; Irvine JH; Stamp LK
Eur J Clin Pharmacol; 2017 Jan; 73(1):71-78. PubMed ID: 27683090
[TBL] [Abstract][Full Text] [Related]
7. Ultra-performance hydrophilic interaction liquid chromatography coupled with tandem mass spectrometry for simultaneous determination of allopurinol, oxypurinol and lesinurad in rat plasma: Application to pharmacokinetic study in rats.
Iqbal M; Ezzeldin E; Herqash RN; Alam O
PLoS One; 2019; 14(3):e0213786. PubMed ID: 30870504
[TBL] [Abstract][Full Text] [Related]
8. Disposition and uric acid lowering effect of oxipurinol: comparison of different oxipurinol formulations and allopurinol in healthy individuals.
Walter-Sack I; de Vries JX; Kutschker C; Ittensohn A; Voss A
Eur J Clin Pharmacol; 1995; 49(3):215-20. PubMed ID: 8665998
[TBL] [Abstract][Full Text] [Related]
9. Oxypurinol, allopurinol and allopurinol-1-riboside in plasma following an acute overdose of allopurinol in a patient with advanced chronic kidney disease.
Kannangara DR; Roberts DM; Furlong TJ; Graham GG; Williams KM; Day RO
Br J Clin Pharmacol; 2012 May; 73(5):828-9. PubMed ID: 22098112
[No Abstract] [Full Text] [Related]
10. Furosemide increases plasma oxypurinol without lowering serum urate--a complex drug interaction: implications for clinical practice.
Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
Rheumatology (Oxford); 2012 Sep; 51(9):1670-6. PubMed ID: 22539486
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics or oral and intravenous allopurinol and intravenous oxypurinol in the horse.
Mills PC; Dunnett M; Smith NC
J Vet Pharmacol Ther; 1995 Dec; 18(6):451-6. PubMed ID: 8789699
[TBL] [Abstract][Full Text] [Related]
12. [A new and quick method for determination of allopurinol and oxipurinol in serum (author's transl)].
Nitsche V; Mascher H
Arzneimittelforschung; 1980; 30(11):1855-7. PubMed ID: 7192993
[TBL] [Abstract][Full Text] [Related]
13. An audit of a therapeutic drug monitoring service for allopurinol therapy.
Kannangara DR; Ramasamy SN; Ray JE; Jones G; Graham GG; Williams KM; Day RO
Ther Drug Monit; 2013 Dec; 35(6):863-6. PubMed ID: 24263644
[TBL] [Abstract][Full Text] [Related]
14. Plasma oxypurinol as a measure of adherence in clinical trials.
Stamp LK; Merriman T; Frampton C; Zhang M; Wallace M; Miner JN; Dalbeth N
Ann Rheum Dis; 2018 Feb; 77(2):313-314. PubMed ID: 28057666
[No Abstract] [Full Text] [Related]
15. Simultaneous determination of allopurinol and oxypurinol by liquid chromatography using immobilized xanthine oxidase with electrochemical detection.
Eisenberg EJ; Conzentino P; Liversidge GG; Cundy KC
J Chromatogr; 1990 Aug; 530(1):65-73. PubMed ID: 2277120
[TBL] [Abstract][Full Text] [Related]
16. Influence of two diets on pharmacokinetic parameters of allopurinol and oxypurinol in healthy beagles.
Bartges JW; Osborne CA; Felice LJ; Koehler LA; Ulrich LK; Bird KA; Chen M
Am J Vet Res; 1997 May; 58(5):511-5. PubMed ID: 9140560
[TBL] [Abstract][Full Text] [Related]
17. Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate-Lowering Response-In Search of a Minimum Effective Oxypurinol Concentration.
Stamp LK; Chapman PT; Barclay M; Horne A; Frampton C; Merriman TR; Wright DFB; Drake J; Dalbeth N
Clin Transl Sci; 2020 Jan; 13(1):110-115. PubMed ID: 31444839
[TBL] [Abstract][Full Text] [Related]
18. Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level.
Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
Clin Pharmacol Ther; 2011 Sep; 90(3):392-8. PubMed ID: 21796116
[TBL] [Abstract][Full Text] [Related]
19. The effect of benzbromarone on allopurinol/oxypurinol kinetics in patients with gout.
Müller FO; Schall R; Groenewoud G; Hundt HK; van der Merwe JC; van Dyk M
Eur J Clin Pharmacol; 1993; 44(1):69-72. PubMed ID: 8436158
[TBL] [Abstract][Full Text] [Related]
20. Quantitative liquid chromatography of allopurinol and oxypurinol in human plasma and urine.
Failler JM; Farinotti R; Dauphin A
Ther Drug Monit; 1985; 7(3):324-8. PubMed ID: 4049473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]